HYPD
HYPD
NASDAQ · Pharmaceuticals

Hyperion Defi Inc

$3.96
+0.11 (+2.86%)
As of Sep 22, 5:05 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +307.6% upside
Low Target $9.68
Average Target $16.14
High Target $20.98
Current Price $3.96
Current
$3.96
Target
$16.14
$9.68 $16.14 avg $20.98
Scenario Analysis
Bear Case
$9.68
144.4%
Low target
Base Case
$16.14
+307.6%
Avg target
Bull Case
$20.98
+429.8%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$13.71
-71.1% from high
52-Week Low
$2.34
+69.2% from low
Target vs 52W High
$16.14
+17.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%